Managing psychosis in Parkinson’s disease without drugs

Psychosis in Parkinson’s disease (PD) is common and the associated poor outcomes mandate a rigorous approach to identification and treatment. Psychosis is associated with depressive symptoms, poor quality of life, impaired activities of daily living, increased caregiver burden, nursing home placement and mortality [1–4]. Although drug treatments have been extensively investigated and reviewed, there has been a paucity of discourse on nondrug treatments, despite the complexities and risks of drug-based treatments in this population [5]. In this editorial, we briefly explore nonpharmacological treatment options and, in the absence of a substantial empirical evidence base, we draw lessons from the dementia...

To view this content, please register now for access

It's completely free